Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations. [electronic resource]
Producer: 20161020Description: 23-8 p. digitalISSN:- 1872-8332
- Aged
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Case-Control Studies
- Class I Phosphatidylinositol 3-Kinases
- ErbB Receptors -- genetics
- Female
- Genotype
- Humans
- Imidazoles -- therapeutic use
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation
- Oximes -- therapeutic use
- Phosphatidylinositol 3-Kinases -- genetics
- Prognosis
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Proto-Oncogene Proteins p21(ras) -- genetics
- Survival Analysis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.